|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and Due from Banks | ||||||||||||||||||||
| Federal Funds Sold | ||||||||||||||||||||
| Securities Available for Sale, at Fair Values (Amortized Cost of $963,978 at December 31, 2023 and $985,599 at December 31, 2022) | ||||||||||||||||||||
| Securities Purchased Under Agreements to Resell | ||||||||||||||||||||
| Securities Available for Sale, at Fair Values (Amortized Cost of $1,086,550 at June 30, 2026 and $1,031,432 at December 31, 2025) | ||||||||||||||||||||
| Mortgage Loans Held for Sale | ||||||||||||||||||||
| Mortgage Receivable | ||||||||||||||||||||
| Total mortgage Loans Held for Sale | ||||||||||||||||||||
| Loans and Lease Receivable, Net of Allowance for Loan Losses of $40,414 and $38,178 at December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Loans and Lease Receivable, Net of Allowance for Loan Losses of $62,458 at June 30, 2026 and $53,959 at December 31, 2025 | ||||||||||||||||||||
| Premises and Equipment, Net | ||||||||||||||||||||
| Accrued Interest Receivable | ||||||||||||||||||||
| Other Equity Securities | ||||||||||||||||||||
| Other Real Estate Owned | ||||||||||||||||||||
| Cash Value of Life Insurance | ||||||||||||||||||||
| Deferred Taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core Deposit and Customer Intangible | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest Bearing | ||||||||||||||||||||
| Interest Bearing | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Federal Funds Purchased | ||||||||||||||||||||
| Securities Sold Under Agreements to Repurchase | ||||||||||||||||||||
| Short Term Borrowings | ||||||||||||||||||||
| Bank Term Funding Program | ||||||||||||||||||||
| Federal Home Loan Bank Borrowings | ||||||||||||||||||||
| Subordinated Debt | ||||||||||||||||||||
| Subordinated Debt - Trust Preferred Securities | ||||||||||||||||||||
| Accrued Interest Payable | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred Stock, No Par Value; 5,000,000 Shares Authorized; 72,010 Shares ($1,000 Liquidation Preference) Issued at both June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common Stock, $1 Par Value; 50,000,000 Shares Authorized; 32,535,659 and 29,510,668 Shares Issued and Outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
